Gut Microbiome that Influence Efficacy of Cancer Immunotherapy

Drugs that boost the immune system have revolutionized immunotherapy for certain cancers. However, only 35 percent of patients with melanoma benefit from such drugs. Specific strains of bacteria that naturally dwell in the intestines can improve the response to immunotherapy for patients being treated for advanced melanoma, finds a study conducted by a research team at the University of Chicago Medicine.

Related Links